BioSpace News Archive

Noven Pharmaceuticals, Inc. today announced that it will present poster data related to its dextroamphetamine transdermal system (d-ATS) for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) at the annual American Academy of Child and Adolescent Psychiatry (AACAP) and Canadian Academy of Child and Adolescent Psychiatry (CACAP) conference October 17-22, 2022.

Athenex, Inc. announced that it has filed a definitive proxy statement with the Securities and Exchange Commission in connection with a special meeting of stockholders scheduled on November 22, 2022.

Medtronic plc released its fiscal year 2022 Integrated Performance Report: Engineering impact.

Todos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, provided a corporate update for shareholders.

EnteroBiotix Limited, the premier full-spectrum microbiome therapeutics company, today announced that it has been granted a Manufacturer’s licence for Investigational Medicinal Products (IMP) by the Medicines and Healthcare Products Regulatory Agency (MHRA) to manufacture microbiome product candidates for clinical trials

GentiBio, Inc., a biotherapeutics company developing engineered T regulatory (Treg) cells (EngTregs) therapies for autoimmune, auto-inflammatory, alloimmune and allergic diseases, today announced the release of preclinical data demonstrating a novel approach for using engineered Tregs to potentially treat and prevent type 1 diabetes (T1D).

Synaptive Medical Inc. announced a joint-development partnership with bioelectronic medicine company Panaxium SAS to incorporate Panaxium’s ultra-flexible iontronic electrocorticography platform into Synaptive’s Modus V robotic exoscope technology.

Pacylex today announced that the US Department of Defense (DOD) awarded The University of Texas MD Anderson Cancer Center $1.4 million to treat Acute Myeloid Leukemia (AML) patients with PCLX-001, a first-in-class N-myristoylation inhibitor in clinical development

BIOMEDevice Boston, the premiere event for medical manufacturing and device engineers, brands, and innovative thought leaders from the region’s top start-ups and medical device OEMs, convened with more than 1,400 attendees and 200-plus exhibitors across the industry under one roof.

BD, a leading global medical technology company, was named to Forbes’ 2022 list of the World’s Best Employers.